HopeStage
Back to all studies
CompletedNCT02703363

Minocycline and Celecoxib Added for Bipolar Depression

About this title

Minocycline and Celecoxib as Adjunctive Treatments of Bipolar Depression

Read the official source — NCT02703363
Medication studyAges 18–65PakistanBipolarity
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 65 years.

Listed locations
Karachi and 3 more locationsSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: August 2016
Recruitment status
Completed
Enrollment listed in the registry
265
Sponsor
Pakistan Institute of Living and Learning
Sponsor type
Research institute
Study type
Drug
Intervention type
Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
Pakistan
Age range
From 18 Years to 65 Years
Official registry ID
NCT02703363
Official title
Show the full official title

Minocycline and Celecoxib as Adjunctive Treatments of Bipolar Depression: A Factorial Design Randomised Controlled Trial

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Karachi

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Pakistan Institute of Living and Learning, a research institute.

Did this study involve medication?

Yes. The study involved medication, including Minocycline, Celecoxib and Placebo.

Who was this study for?

Listed age limits: 18 years to 65 years.

Want to explore more studies?

Explore studies